Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
07-Feb-17 Singapore-based health technology startup CXA Group, which offers an employee benefits and wellness marketplace platform, has raised USD25 mn in Series B funding in a round led by B Capital Group and EDBI. The SaaS platform uses health screening, lifestyle risks, and data from claims and wearable sensors to predict future premium costs. [image: CXA Group]
Read More
06-Feb-17 China's Vincent Medical Holdings has made a $3 million investment for a 15 percent stake in Isreal's InovyTec Medical Solutions, a company that makes medical devices for emergency medicine and trauma care. Vincent Medical Holdings, a Chinese holding company does research and development and manufacture and sale of medical devices. [image: Vincent Medical]
Read More
03-Feb-17 The Korean government will invest KRW315.7 bn (USD276 mn) to secure original technologies for bio sectors such as new drugs, medical devices, future medical care, genomics and brain science in 2017. This includes KRW263 bn for bio-medical technology development projects. This year's budget is 31% more than last year’s. [image: Business Korea]
Read More
02-Feb-17 While the healthcare sector claims to be 'satisfied' with the move to formulate new rules regarding medical devices, industry still seeks more clarity. The rules are proposed to be internationally harmonised to attract investments, and thereby reduce costs of devices. [image: Deccan Herald]
Read More
02-Feb-17 Aiming to attract more tourists and boost trade, the Indian government has approved a new liberalised visa policy that includes a long-term multiple-entry comprehensive visa by merging tourist, business, medical and conference visas into one. Citizens from Pakistan and China will not be covered under the new liberalised visa policy. [image: IMTJ]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: